DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/btvgnw/the_us_specialty) has announced the addition of the "The US Specialty Pharmaceutical Market Report: 2015 Edition" report to their offering.
The report, The US Specialty Pharmaceuticals Market: 2015 Edition analyzes the growth and development of specialty pharmaceutical in the US. Apart from providing a competitive landscape of the market, the report also profiles the major companies including Amgen, Pfizer, Johnson & Johnson and Merck and Co., along with a discussion of their key financials and business strategies.
Specialty pharmaceuticals are typically high-cost, scientifically engineered drugs used to treat complex, chronic conditions that require special storage, warranting special handling, and temperature-control monitoring. These products are often manufactured for small populations of people suffering from somewhat rare, life-threatening and debilitating diseases. The specialty pharmaceuticals are mostly injectable or infused medicines but may also encompass oral medications.
Currently, specialty drugs are one of the fastest growing segments of the overall pharmaceutical market, as sales growth is being driven by improved efficacy compared with currently marketed therapies, while expanded indications for already marketed drugs and off label prescribing can drive sales of these drugs by increasing potential patient populations. The key factors driving growth of the US specialty pharmaceutical industry include accelerating US aging population, ameliorating economic condition, increased life expectancy, and increasing healthcare expenditure. Apart from these growth drivers, many challenges lie ahead for the specialty pharmaceutical market in the US, including the changes in reimbursement process due to healthcare reforms, regulatory pressures, narrowing specialty pharmacy networks and lack of access to specialty pharmacy products.
Some of the noteworthy trends and developments of this industry include novel specialty product launches, growing Hepatitis-C segment, increased spending on specialty drugs and ongoing merger & acquisition activities. The percentage of specialty pharmaceuticals sales of the overall US pharmaceuticals sales continues to rise.
Key Topics Covered:
1.1 Specialty Pharmaceuticals Vs Traditional Drugs
1.2 Applications of Specialty Pharmaceuticals
1.3 Specialty Pharmacy Services
1.4 Specialty Product Distribution
1.5 Specialty Pharma Manufacturer Services
1.6 Value Proposition of Specialty Pharmacy
2. The US Specialty Pharmaceutical Market
2.1 The US Specialty Market by Therapeutic Area
2.2 Specialty Pharmacy in the US
3. Market Dynamics
3.1 Key Trends and Developments
3.2 Growth Drivers
3.4 Specialty Pharmaceuticals: Pipeline Update
4. Competitive Landscape
4.1 Competition by Drugs
4.2 Competition by Mail Pharmacy
4.3 Competition by Specialty Distributor
5. Company Profiles
5.1 Johnson & Johnson
5.2 Amgen Inc.
5.3 Merck & Co.
5.4 Pfizer Inc.
6. Market Outlook
6.1 Market Forecast
6.2 Forecast Methodology
For more information visit http://www.researchandmarkets.com/research/btvgnw/the_us_specialty